No earnings within 2 weeks of this transaction.
| Insider | Venker Eric |
|---|---|
| Title | President & Immunovant CEO |
| Transaction Date | Jun 24, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Shares |
| Direct/Indirect | Direct |
| Filing Date | Jun 26, 2026 |
| Shares Sold | 46,234 |
| Price per Share | $33.51 |
| Total Value | $1,549,301.34 |
| Shares Owned After | 1,613,063 |
| Derivative | No |
| Accession Number | 0001635088-26-000071 |
| Document | View SEC Filing |